| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000004275 |
| Receipt No. | R000005127 |
| Official scientific title of the study | Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmatics |
| Date of disclosure of the study information | 2010/09/30 |
| Last modified on | 2018/01/10 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmatics | |
| Title of the study (Brief title) | Effects of ICS+LABA on Tregs in asthma | |
| Region |
|
|
| Condition | ||
| Condition | mild asthma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim is to investigate the effects of inhaled budesonide and formoterol combination on induced sputum regulatory T cells in asthmatics and compare with placebo and inhaled budesonide alone therapy. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Improvement of induced sputum regulatory T cells |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | inhaled budesonide and formoterol combination | |
| Interventions/Control_2 | inhaled budesonide | |
| Interventions/Control_3 | placebo | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. mild asthmatics in according to GINA 2006 guideline
2. PC20 to methacholine < 16mg/mL 3. nonsmoker 4. stable within 4wks |
|||
| Key exclusion criteria | 1. user of inhaled, oral, or injective corticosteroids, leukotriene antagonists, long acting-beta2 agonists, DSCG, theophylline, immunosupressants, anti-allergic or anti-histamine agents within 4wks.
2. respiratory infections within 4wks. 3. histories of other severe organ diseases. 4. histories of psychological diseases. 5. pregnancy or nursing. |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Tomotaka Kawayama |
| Organization | Kurume University School of Medicine |
| Division name | Division of respirology, neurology, and rheumatology |
| Address | 67 Asahi-machi, Kurume, Fukuoka, Japan |
| TEL | 094-31-7560 |
| kawayama_tomotaka@med.kurume-u.ac.jp | |
| Public contact | |
| Name of contact person | Tomotaka Kawayama |
| Organization | Kurume University School of Medicine |
| Division name | Division of respirology, neurology, and rheumatology |
| Address | 67 Asahimachi, Kurume |
| TEL | 0942-31-7560 |
| Homepage URL | |
| kawayama_tomotaka@med.kurume-u.ac.jp | |
| Sponsor | |
| Institute | Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005127 |